Access
This article is part of Nature's premium content.
Published online 9 December 2004 | Nature | doi:10.1038/news041206-11
News
Compound J tackles tuberculosis
Next generation of drugs perform well against resistant strains.
Tuberculosis kills 2 million people a year, but a promising drug may save some of them, if it makes it to the clinic. The compound has a different mode of action from existing therapies so it acts more quickly, and works on patients whose infections are resistant to today's drugs.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.